References
1. Paleri V, Urbano T, Mehanna H, Repanos C, Lancaster J, Roques T, et
al. Management of neck metastases in head and neck cancer: United
Kingdom National Multidisciplinary Guidelines. The Journal of
Laryngology & Otology. 2016;130(S2):S161-S9.
2. Allanson BM, Low TH, Clark JR, Gupta R. Squamous Cell Carcinoma of
the External Auditory Canal and Temporal Bone: An Update. Head Neck
Pathol. 2018;12(3):407-18.
3. Moody SA, Hirsch BE, Myers EN. Squamous cell carcinoma of the
external auditory canal: an evaluation of a staging system. Am J Otol.
2000;21(4):582-8.
4. Masterson L, Rouhani M, Donnelly NP, Tysome JR, Patel P, Jefferies
SJ, et al. Squamous cell carcinoma of the temporal bone: clinical
outcomes from radical surgery and postoperative radiotherapy. Otol
Neurotol. 2014;35(3):501-8.
5. Roland N, Paleri V. Head and neck cancer: multidisciplinary
management guidelines. Restorative Dentistry/Oral Rehabilitation London:
ENT UK. 2011:56-62.
6. Paleri V, Roland N. Introduction to the United Kingdom national
multidisciplinary guidelines for head and neck cancer. The Journal of
Laryngology & Otology. 2016;130(S2):S3-S4.
7. Rinaldo A, Ferlito A, Suarez C, Kowalski LP. Nodal disease in
temporal bone squamous carcinoma. Acta Otolaryngol. 2005;125(1):5-8.
8. Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et
al. Preferred reporting items for systematic review and meta-analysis
protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4:1.
9. Wells G, Shea B, O’Connell D, Peterson J, Welch V, Losos M, et al.
Newcastle-Ottawa quality assessment scale cohort studies. University of
Ottawa. 2014.
10. Normand SL. Meta-analysis: formulating, evaluating, combining, and
reporting. Stat Med. 1999;18(3):321-59.
11. Sterne JA, Egger M. Funnel plots for detecting bias in
meta-analysis: guidelines on choice of axis. J Clin Epidemiol.
2001;54(10):1046-55.
12. Chang CH, Shu MT, Lee JC, Leu YS, Chen YC, Lee KS. Treatments and
outcomes of malignant tumors of external auditory canal. Am J
Otolaryngol. 2009;30(1):44-8.
13. Cristalli G, Manciocco V, Pichi B, Marucci L, Arcangeli G, Telera S,
et al. Treatment and outcome of advanced external auditory canal and
middle ear squamous cell carcinoma. J Craniofac Surg. 2009;20(3):816-21.
14. Gidley PW, Roberts DB, Sturgis EM. Squamous cell carcinoma of the
temporal bone. Laryngoscope. 2010;120(6):1144-51.
15. Matoba T, Hanai N, Suzuki H, Nishikawa D, Tachibana E, Okada T, et
al. Treatment and Outcomes of Carcinoma of the External and Middle Ear:
The Validity of En Bloc Resection for Advanced Tumor. Neurol Med Chir
(Tokyo). 2018;58(1):32-8.
16. McRackan TR, Fang TY, Pelosi S, Rivas A, Dietrich MS, Wanna GB, et
al. Factors associated with recurrence of squamous cell carcinoma
involving the temporal bone. Ann Otol Rhinol Laryngol.
2014;123(4):235-9.
17. Morris LG, Mehra S, Shah JP, Bilsky MH, Selesnick SH, Kraus DH.
Predictors of survival and recurrence after temporal bone resection for
cancer. Head Neck. 2012;34(9):1231-9.
18. Ng SY, Pua KC, Zahirrudin Z. Temporal bone squamous cell carcinoma -
Penang experience. Med J Malaysia. 2015;70(6):367-8.
19. Zanoletti E, Danesi G. The problem of nodal disease in squamous cell
carcinoma of the temporal bone. Acta Otolaryngol. 2010;130(8):913-6.
20. Nakagawa T, Kumamoto Y, Natori Y, Shiratsuchi H, Toh S, Kakazu Y, et
al. Squamous cell carcinoma of the external auditory canal and middle
ear: an operation combined with preoperative chemoradiotherapy and a
free surgical margin. Otol Neurotol. 2006;27(2):242-8; discussion 9.
21. Ogura JH, Biller HF, Wette R. Elective neck dissection for
pharyngeal and laryngeal cancers. An evaluation. Ann Otol Rhinol
Laryngol. 1971;80(5):646-50.
22. Lee JG, Krause CJ. Radical neck dissection: Elective, therapeutic,
and secondary. Arch Otolaryngol. 1975;101(11):656-9.
23. Prasad SC, D’Orazio F, Medina M, Bacciu A, Sanna M. State of the art
in temporal bone malignancies. Curr Opin Otolaryngol Head Neck Surg.
2014;22(2):154-65.
24. Mehta GU, Muelleman TJ, Brackmann DE, Gidley PW. Temporal bone
resection for lateral skull-base malignancies. J Neurooncol.
2020;150(3):437-44.
25. Ferlito A, Rinaldo A, Silver CE, Gourin CG, Shah JP, Clayman GL, et
al. Elective and therapeutic selective neck dissection. Oral Oncol.
2006;42(1):14-25.
26. Gujral DM, Chahal N, Senior R, Harrington KJ, Nutting CM.
Radiation-induced carotid artery atherosclerosis. Radiother Oncol.
2014;110(1):31-8.
27. Bacciu A, Clemente IA, Piccirillo E, Ferrari S, Sanna M. Guidelines
for treating temporal bone carcinoma based on long-term outcomes. Otol
Neurotol. 2013;34(5):898-907.
28. Zhang T, Li W, Dai C, Chi F, Wang S, Wang Z. Evidence-based surgical
management of T1 or T2 temporal bone malignancies. Laryngoscope.
2013;123(1):244-8.
29. Seligman KL, Sun DQ, Ten Eyck PP, Schularick NM, Hansen MR. Temporal
bone carcinoma: Treatment patterns and survival. Laryngoscope.
2020;130(1):E11-E20.
30. Xie B, Zhang T, Dai C. Survival outcomes of patients with temporal
bone squamous cell carcinoma with different invasion patterns. Head
Neck. 2015;37(2):188-96.
31. Ge X, Liao Z, Yuan J, Mao D, Li Y, Yu E, et al. Radiotherapy-related
quality of life in patients with head and neck cancers: a meta-analysis.
Support Care Cancer. 2020;28(6):2701-12.
32. Pfister DG, Spencer S, Adelstein D, Adkins D, Anzai Y, Brizel DM, et
al. Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice
Guidelines in Oncology. J Natl Compr Canc Netw. 2020;18(7):873-98.